Impact of an Antimicrobial Stewardship Program on Antibiotic Use at a Nonfreestanding Children's Hospital

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e36-e40. doi: 10.1093/jpids/piw059.

Abstract

Background: Pediatric stewardship programs have been successful at reducing unnecessary antibiotic use. Data from nonfreestanding children's hospitals are currently limited. This study is an analysis of antibiotic use after implementation of an antimicrobial stewardship program at a community nonfreestanding children's hospital.

Methods: In April 2013, an antimicrobial stewardship program that consisted of physician-group engagement and pharmacist prospective auditing and feedback was initiated. We compared antibiotic use in the preintervention period (April 2012 to March 2013) with that in the postintervention period (April 2013 to March 2015) in all units except the neonatal intensive care unit and the emergency department. In addition, drug-acquisition costs, antibiotic-specific use, death, length of stay, and case-mix index were examined.

Results: Antibiotic use decreased by 16.8% (95% confidence interval, 18.0% to -9.2%; P < .001) in the postintervention period. Vancomycin use decreased by 38% (P = .001), whereas antipseudomonal β-lactam use was unaltered. Drug-acquisition cost savings were estimated to be $67 000/year over the 2-year postintervention period. Lengths of stay and mortality rates were unchanged in the postintervention period after adjusting for case-mix index.

Conclusions: Implementation of a simple stewardship initiative with limited resources at a community nonfreestanding children's hospital effectively reduced antibiotic use without an overt negative impact on overall clinical outcomes. The results of this study suggest that nonfreestanding children's hospitals can achieve substantial reductions in antibiotic use despite limited resources.

Keywords: antimicrobial consumption; antimicrobial stewardship; audit with feedback; children’s hospital; duration of therapy.

MeSH terms

  • Anti-Bacterial Agents / classification
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Stewardship*
  • Bacterial Infections / drug therapy*
  • Drug Prescriptions / statistics & numerical data*
  • Drug Utilization / statistics & numerical data
  • Drug Utilization Review
  • Hospitals, Pediatric* / economics
  • Hospitals, Pediatric* / statistics & numerical data
  • Humans
  • Non-Randomized Controlled Trials as Topic
  • Oregon
  • Pharmacy Service, Hospital / economics
  • Pharmacy Service, Hospital / statistics & numerical data
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'
  • Tertiary Care Centers
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents